Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Shapiro

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Critical Reviews in Clinical Laboratory Sciences|October 19, 2002
Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapyPaul Shapiro
Theoretical Medicine and Bioethics|August 15, 2006
Moral agency in other animalsPaul Shapiro
Chemistry & Biology|August 26, 2006
Discovering new MAP kinase inhibitorsPaul Shapiro
The Journal of Biological Chemistry|May 26, 2019
A promiscuous kinase inhibitor reveals secrets to cancer cell survivalPaul Shapiro
Methods in Molecular Biology (Clifton, N.J.)|September 3, 2010
Use of inhibitors in the study of MAP kinasesKimberly Burkhard, Paul Shapiro
The Journal of Biological Chemistry|May 13, 2005
Cdc2-mediated inhibition of epidermal growth factor activation of the extracellular signal-regulated kinase pathway during mitosisSurabhi Dangi, Paul Shapiro
Advances in Pharmacology (San Diego, Calif.)|July 21, 2024
Progress in the development of ERK1/2 inhibitors for treating cancer and other diseasesLena Grogan, Paul Shapiro
Facial Plastic Surgery Clinics of North America|September 11, 2013
Hairline design and frontal hairline restorationRonald Shapiro, Paul Shapiro
Cellular Signalling|May 14, 2003
Requirement for phosphatidylinositol-3 kinase activity during progression through S-phase and entry into mitosisSurabhi Dangi, Hyukjin Cha, Paul Shapiro
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 30, 2012
Structure of extracellular signal-regulated kinase 2 in complex with ATP and ADPJun Zhang, Paul Shapiro, Edwin Pozharski
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Critical Reviews in Clinical Laboratory Sciences|October 19, 2002
Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapyPaul Shapiro
Theoretical Medicine and Bioethics|August 15, 2006
Moral agency in other animalsPaul Shapiro
Chemistry & Biology|August 26, 2006
Discovering new MAP kinase inhibitorsPaul Shapiro
The Journal of Biological Chemistry|May 26, 2019
A promiscuous kinase inhibitor reveals secrets to cancer cell survivalPaul Shapiro
Methods in Molecular Biology (Clifton, N.J.)|September 3, 2010
Use of inhibitors in the study of MAP kinasesKimberly Burkhard, Paul Shapiro
The Journal of Biological Chemistry|May 13, 2005
Cdc2-mediated inhibition of epidermal growth factor activation of the extracellular signal-regulated kinase pathway during mitosisSurabhi Dangi, Paul Shapiro
Advances in Pharmacology (San Diego, Calif.)|July 21, 2024
Progress in the development of ERK1/2 inhibitors for treating cancer and other diseasesLena Grogan, Paul Shapiro
Facial Plastic Surgery Clinics of North America|September 11, 2013
Hairline design and frontal hairline restorationRonald Shapiro, Paul Shapiro
Cellular Signalling|May 14, 2003
Requirement for phosphatidylinositol-3 kinase activity during progression through S-phase and entry into mitosisSurabhi Dangi, Hyukjin Cha, Paul Shapiro
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 30, 2012
Structure of extracellular signal-regulated kinase 2 in complex with ATP and ADPJun Zhang, Paul Shapiro, Edwin Pozharski
Pageof 8